In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Atossa Genetics Inc.

www.atossagenetics.com

Latest From Atossa Genetics Inc.

Pipeline Watch: Phase III Trials Initiated For AMT-061, RP-G28 And APL-2

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

Medtech Execs On The Move, October 2015

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device

Medical Device Deals Update, June-July 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced May-June 2015.

Medical Device

Medtech Execs On The Move, June-July 2015

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Cytology
    • Molecular Diagnostics & Genetic Testing
  • Medical Devices
    • Diagnostic Equipment & Supplies
  • Services
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Atossa Genetics Inc.
  • Senior Management
  • Steven Quay, MD, PhD, CEO
    Kyle Guse, CFO
    Cindy Atha, VP, Sales & Mktg.
    Jelle Kylstra, MD, VP, Clinical R&D
  • Contact Info
  • Atossa Genetics Inc.
    Phone: (206) 588-0256
    2345 Eastlake Ave. E
    Ste. 201
    Seattle, WA 98102
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register